| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Revenue | $217.5M | +22.9% |
| Cost of Revenue | $39.5M | +20.1% |
| Gross Profit | $178.0M | +23.6% |
| R&D Expense | $61.8M | +42.2% |
| SG&A Expense | $57.7M | +43.1% |
| Operating Income | -$66.6M | -134.0% |
| Interest Expense | $3.6M | -20.8% |
| Pre-tax Income | -$64.6M | -37.8% |
| Income Tax | $1.7M | +89.8% |
| Net Income | -$66.3M | -38.7% |
| EPS (Basic) | -$0.78 | +31.6% |
| EPS (Diluted) | -$0.78 | +31.6% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $128.8M | +0.3% |
| Accounts Receivable | $71.4M | +27.6% |
| Current Assets | $457.4M | -1.4% |
| Total Assets | $494.2M | -0.6% |
| Current Liabilities | $125.8M | +24.9% |
| Long-term Debt | $39.6M | +0.3% |
| Total Liabilities | $178.0M | +10.5% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$45.0M | -22.4% |
| Capital Expenditures | $1.6M | +45.5% |
| Investing Cash Flow | $30.0M | +112.3% |
| Financing Cash Flow | $15.9M | -94.9% |
| Free Cash Flow | -$46.6M | -23.0% |
| Stockholders' Equity |
| $316.2M |
| -5.9% |